Mar 31, 2017

SRI International Receives U.S. FDA Clearance for Investigational New Drug Application Evaluating Novel Oral Treatment to Combat Radiation Exposure

Posted by in category: biotech/medical

Creating oral formulations of intravenous (IV) medication is a daunting challenge. Scientists at SRI Biosciences are using advanced formulation tools and experience to overcome the challenges, with the goal of developing drugs that could easily be distributed to people if needed.

Read more

Comments are closed.